Clinical Trial Update: MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of co-administering MK-2060 with clopidogrel in participants with end-stage renal disease. The study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• MK-2060

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: End-Stage Renal Disease, Kidney Failure, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2024-10-17